Pan-European cancer care group Amethyst Healthcare is eyeing further expansion following its acquisition by mid-market private equity firm Fremman Capital in April. Maria Davies met CEO Stéphane Carré to find out how innovation is driving growth and why the UK market is central to its plans Amethyst Healthcare is ramping up its presence in the…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
